Chronic Lyme disease: the controversies and the science

References

• Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N. Engl. J. Med.323(21), 1438–1444 (1990).
   PubMed Web of Science ®Google Scholar
• Fallon BA, Keilp JG, Corbera KM et al. A randomized, placebo-controlled trial of repeated iv antibiotic therapy for Lyme encephalopathy. Neurology70(13), 992–1003 (2008).
   PubMed Web of Science ®Google Scholar
• Kaplan RF, Trevino RP, Johnson GM et al. Cognitive function in post-treatment Lyme disease: do additional antibiotics help? Neurology60(12), 1916–1922 (2003).
   PubMed Web of Science ®Google Scholar
• Klempner MS, Hu LT, Evans J et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N. Engl. J. Med.345(2), 85–92 (2001).
   PubMed Web of Science ®Google Scholar
• Krupp LB, Hyman LG, Grimson R et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology60(12), 1923–1930 (2003).
   PubMed Web of Science ®Google Scholar
• Steere AC, Levin RE, Molloy PJ et al. Treatment of Lyme arthritis. Arthritis Rheum.37(6), 878–888 (1994).
   PubMed Web of Science ®Google Scholar
• Shadick NA, Phillips CB, Logigian EL et al. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann. Intern. Med.121(8), 560–567 (1994).
   PubMed Web of Science ®Google Scholar
• Sigal LH. Persisting complaints attributed to chronic Lyme disease: possible mechanisms and implications for management. Am. J. Med.96(4), 365–374 (1994).
   PubMed Web of Science ®Google Scholar
• Société de pathologie infectieuse de langue française. Lyme borreliose: diagnostic, therapeutic and preventive approaches – long text. Med. Mal. Infect.37(Suppl. 3), S153–S174 (2007).
   PubMed Web of Science ®Google Scholar
• Neuroborreliose. Leitlinien der Deutschen Gesellschaft für Neurologie. [Neuroborreliosis: Guidelines of the German Society for Neurology] Leitlinien-Register Nr 030/071 (2008) (In German).
   Google Scholar
• Läkemedelsbehandling av borreliainfektion – ny rekommendation. [Drug treatment of Lyme disease: New Recommendation]. Information Från Läkemedelsverket4, 12–17 (2009) (In Swedish).
   Google Scholar
• Kutane Manifestationen der Lyme Borreliose. Leitlinien der Deutschen Dermatologischen Gesellschaft, Arbeitsgemeinschaft für Dermatologische Infektiologie [Cutaneous manifestations of Lyme borreliosis. Guidelines of the German Society of Dermatology, Dermatologic Association for Infectious Diseases]. Leitlinien-Register Nr 013/044 (2009) (In German).
   Google Scholar
• (AAP) AAoP. Lyme disease (Lyme Borreliosis, Borrelia burgdorferi infection). In: Red Book: 2009 Report of the Committee on Infectious Diseases. 28th Ed. Pickering LK, Baker CJ, Kimberlin DW, Long SS (Eds). American Academy of Pediatrics, Elk Grove Village, IL, USA, 430–435 (2009).
   Google Scholar
• Dessau RB, Bangsborg JM, Jensen TP, Hansen K, Lebech AM, Andersen CO. Laboratory diagnosis of infection caused by Borrelia burgdorferi. Ugeskr. Laeg.168(34), 2805–2807 (2006).
   PubMedGoogle Scholar
• Evison J, Aebi C, Francioli P et al. Diagnostic et traitement de la borréliose de Lyme chez l’adulte et l’enfant: recommandations de la Société suisse d’infectiologie [Diagnosis and treatment of Lyme disease in adults and children: Recommendations of the Swiss Society of Infectious Diseases]. Revue Médicale Suisse2, 919–924 (2006) (In French).
   PubMedGoogle Scholar
• Flisiak R, Pancewicz S. Diagnostics and treatment of Lyme borreliosis. Recommendations of Polish Society of Epidemiology and Infectious Diseases. Przegl Epidemiol.62(1), 193–199 (2008).
   PubMedGoogle Scholar
• Halperin JJ, Shapiro ED, Logigian E et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology69(1), 91–102 (2007).
   PubMed Web of Science ®Google Scholar
• Lantos PM, Charini WA, Medoff G et al. Final report of the Lyme disease review panel of the Infectious Diseases Society of America. Clin. Infect. Dis.51(1), 1–5 (2010).
   PubMed Web of Science ®Google Scholar
• Ljostad U, Mygland A. Lyme borreliosis in adults. Tidsskr. Nor. Laegeforen.128(10), 1175–1178 (2008).
   PubMedGoogle Scholar
• Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur. J. Neurol.17(1), 8–16, e11–e14 (2010).
   PubMed Web of Science ®Google Scholar
• O’Connell S. Recommendations for the diagnosis and treatment of Lyme borreliosis: guidelines and consensus papers from specialist societies and expert groups in Europe and North America. Presented at: Federation of Infections Societies (FIS) “Infection 2009” conference. Birmingham, UK, 11–13 November, 2009.
   Google Scholar
• Oksi J. Diagnostics and treatment of Lyme borreliosis. Duodecim116(6), 605–612 (2000).
   PubMedGoogle Scholar
• Speelman P, de Jongh BM, Wolfs TF, Wittenberg J. Guideline ‘Lyme borreliosis’. Ned. Tijdschr. Geneeskd.148(14), 659–663 (2004).
   PubMedGoogle Scholar
• Strle F. Principles of the diagnosis and antibiotic treatment of Lyme borreliosis. Wien. Klin. Wochenschr.111(22–23), 911–915 (1999).
   PubMed Web of Science ®Google Scholar
• Vanousova D, Hercogova J. Lyme borreliosis treatment. Dermatol. Ther.21(2), 101–109 (2008).
   PubMed Web of Science ®Google Scholar
• Wormser GP, Dattwyler RJ, Shapiro ED et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis.43(9), 1089–1134 (2006).
   PubMed Web of Science ®Google Scholar
• Stanek G, O’Connell S, Cimmino M et al. European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien. Klin. Wochenschr.108(23), 741–747 (1996).
   PubMed Web of Science ®Google Scholar
• Johnson M, Feder HM Jr. Chronic Lyme disease: a survey of Connecticut primary care physicians. J. Pediatr.157(6), 1025–1029. e1–e2 (2010).
   PubMed Web of Science ®Google Scholar
• Murray T, Feder HM Jr. Management of tick bites and early Lyme disease: a survey of Connecticut physicians. Pediatrics108(6), 1367–1370 (2001).
   PubMed Web of Science ®Google Scholar
• Cameron D, Gaito A, Harris N et al. Evidence-based guidelines for the management of Lyme disease. Expert Rev. Anti Infect. Ther.2(Suppl. 1), S1–S13 (2004).
   PubMedGoogle Scholar
• Reid MC, Schoen RT, Evans J, Rosenberg JC, Horwitz RI. The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann. Intern. Med.128(5), 354–362 (1998).
   PubMed Web of Science ®Google Scholar
• Sigal LH. Summary of the first 100 patients seen at a Lyme disease referral center. Am. J. Med.88(6), 577–581 (1990).
   PubMed Web of Science ®Google Scholar
• Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA269(14), 1812–1816 (1993).
   PubMed Web of Science ®Google Scholar
• Hassett AL, Radvanski DC, Buyske S, Savage SV, Sigal LH. Psychiatric comorbidity and other psychological factors in patients with “chronic Lyme disease”. Am. J. Med.122(9), 843–850 (2009).
   PubMed Web of Science ®Google Scholar
• Qureshi MZ, New D, Zulqarni NJ, Nachman S. Overdiagnosis and overtreatment of Lyme disease in children. Pediatr. Infect. Dis. J.21(1), 12–14 (2002).
   PubMed Web of Science ®Google Scholar
• Rose CD, Fawcett PT, Gibney KM, Doughty RA. The overdiagnosis of Lyme disease in children residing in an endemic area. Clin. Pediatr. (Phila.)33(11), 663–668 (1994).
   PubMed Web of Science ®Google Scholar
• Djukic M, Schmidt-Samoa C, Nau R, Von Steinbuchel N, Eiffert H, Schmidt H. The diagnostic spectrum in patients with suspected chronic Lyme neuroborreliosis – the experience from one year of a university hospital’s Lyme neuroborreliosis outpatients clinic. Eur. J. Neurol.18(4), 547–555 (2010).
   PubMedGoogle Scholar
• Burdge DR, O’Hanlon DP. Experience at a referral center for patients with suspected Lyme disease in an area of nonendemicity: first 65 patients. Clin. Infect. Dis.16(4), 558–560 (1993).
   PubMed Web of Science ®Google Scholar
• Tugwell P, Dennis DT, Weinstein A et al. Laboratory evaluation in the diagnosis of Lyme disease. Ann. Intern. Med.127(12), 1109–1123 (1997).
   PubMed Web of Science ®Google Scholar
• Smith HV, Gray JS, McKenzie G. A Lyme borreliosis human serosurvey of asymptomatic adults in Ireland. Zentralbl. Bakteriol.275(3), 382–389 (1991).
   PubMedGoogle Scholar
• Zhioua E, Gern L, Aeschlimann A, Sauvain MJ, Van der Linden S, Fahrer H. Longitudinal study of Lyme borreliosis in a high risk population in Switzerland. Parasite5(4), 383–386 (1998).
   PubMedGoogle Scholar
• Steere AC, Sikand VK, Meurice F et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N. Engl. J. Med.339(4), 209–215 (1998).
   PubMed Web of Science ®Google Scholar
• Steere AC, Sikand VK, Schoen RT, Nowakowski J. Asymptomatic infection with Borrelia burgdorferi. Clin. Infect. Dis.37(4), 528–532 (2003).
   PubMed Web of Science ®Google Scholar
• Fahrer H, van der Linden SM, Sauvain MJ, Gern L, Zhioua E, Aeschlimann A. The prevalence and incidence of clinical and asymptomatic Lyme borreliosis in a population at risk. J. Infect. Dis.163(2), 305–310 (1991).
   PubMed Web of Science ®Google Scholar
• Gustafson R, Svenungsson B, Gardulf A, Stiernstedt G, Forsgren M. Prevalence of tick-borne encephalitis and Lyme borreliosis in a defined Swedish population. Scand. J. Infect. Dis.22(3), 297–306 (1990).
   PubMed Web of Science ®Google Scholar
• Steere AC, Taylor E, Wilson ML, Levine JF, Spielman A. Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population. J. Infect. Dis.154(2), 295–300 (1986).
   PubMed Web of Science ®Google Scholar
• Seidel MF, Domene AB, Vetter H. Differential diagnoses of suspected Lyme borreliosis or post-Lyme-disease syndrome. Eur. J. Clin. Microbiol. Infect. Dis.26(9), 611–617 (2007).
   PubMed Web of Science ®Google Scholar
• Savely V. Lyme disease: a diagnostic dilemma. Nurse Pract.35(7), 44–50 (2010).
   PubMedGoogle Scholar
• Stricker RB, Johnson L. ‘Rare’ infections mimicking multiple sclerosis: Consider Lyme disease. Clin. Neurol. Neurosurg.113(3), 259–60 (2010).
   PubMed Web of Science ®Google Scholar
• Fritzsche M. Chronic Lyme borreliosis at the root of multiple sclerosis – is a cure with antibiotics attainable? Med. Hypotheses64(3), 438–448 (2005).
   PubMed Web of Science ®Google Scholar
• Bacon RM, Kugeler KJ, Mead PS. Surveillance for Lyme disease – United States, 1992–2006. MMWR Surveill. Summ.57(10), 1–9 (2008).
   PubMedGoogle Scholar
• Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol. Sci.22(2), 117–139 (2001).
   PubMed Web of Science ®Google Scholar
• Coyle PK. Borrelia burgdorferi antibodies in multiple sclerosis patients. Neurology39(6), 760–761 (1989).
   PubMed Web of Science ®Google Scholar
• Coyle PK, Krupp LB, Doscher C. Significance of reactive Lyme serology in multiple sclerosis. Ann. Neurol.34(5), 745–747 (1993).
   PubMed Web of Science ®Google Scholar
• Halperin JJ, Volkman DJ, Wu P. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology41(10), 1571–1582 (1991).
   PubMed Web of Science ®Google Scholar
• Barsky AJ, Borus JF. Functional somatic syndromes. Ann. Intern. Med.130(11), 910–921 (1999).
   PubMed Web of Science ®Google Scholar
• Hatcher S, Arroll B. Assessment and management of medically unexplained symptoms. BMJ336(7653), 1124–1128 (2008).
   PubMed Web of Science ®Google Scholar
• Smith RC, Dwamena FC. Classification and diagnosis of patients with medically unexplained symptoms. J. Gen. Intern. Med.22(5), 685–691 (2007).
   PubMed Web of Science ®Google Scholar
• Dinerman H, Steere AC. Lyme disease associated with fibromyalgia. Ann. Intern. Med.117(4), 281–285 (1992).
   PubMed Web of Science ®Google Scholar
• Hickie I, Davenport T, Wakefield D et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ333(7568), 575 (2006).
   PubMed Web of Science ®Google Scholar
• Kalish RA, Kaplan RF, Taylor E, Jones-Woodward L, Workman K, Steere AC. Evaluation of study patients with Lyme disease, 10–20-year follow-up. J. Infect. Dis.183(3), 453–460 (2001).
   PubMed Web of Science ®Google Scholar
• Shadick NA, Phillips CB, Sangha O et al. Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease. Ann. Intern. Med.131(12), 919–926 (1999).
   PubMed Web of Science ®Google Scholar
• Ravdin LD, Hilton E, Primeau M, Clements C, Barr WB. Memory functioning in Lyme borreliosis. J. Clin. Psychiatry57(7), 282–286 (1996).
   PubMed Web of Science ®Google Scholar
• Kaplan RF, Jones-Woodward L. Lyme encephalopathy: a neuropsychological perspective. Semin. Neurol.17(1), 31–37 (1997).
   PubMed Web of Science ®Google Scholar
• Seltzer EG, Shapiro ED, Gerber MA. Long-term outcomes of lyme disease. JAMA283(23), 3068–3069 (2000).
   PubMedGoogle Scholar
• Buchwald D, Umali P, Umali J, Kith P, Pearlman T, Komaroff AL. Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific Northwest health care system. Ann. Intern. Med.123(2), 81–88 (1995).
   PubMed Web of Science ®Google Scholar
• Chen MK. The epidemiology of self-perceived fatigue among adults. Prev. Med.15(1), 74–81 (1986).
   PubMed Web of Science ®Google Scholar
• Luo N, Johnson JA, Shaw JW, Feeny D, Coons SJ. Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Med. Care43(11), 1078–1086 (2005).
   PubMed Web of Science ®Google Scholar
• Croft P, Rigby AS, Boswell R, Schollum J, Silman A. The prevalence of chronic widespread pain in the general population. J. Rheumatol.20(4), 710–713 (1993).
   PubMed Web of Science ®Google Scholar
• Cerar D, Cerar T, Ruzic-Sabljic E, Wormser GP, Strle F. Subjective symptoms after treatment of early Lyme disease. Am. J. Med.123(1), 79–86 (2010).
   PubMed Web of Science ®Google Scholar
• Barsic B, Maretic T, Majerus L, Strugar J. Comparison of azithromycin and doxycycline in the treatment of erythema migrans. Infection28(3), 153–156 (2000).
   PubMed Web of Science ®Google Scholar
• Dattwyler RJ, Luft BJ, Kunkel MJ et al. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N. Engl. J. Med.337(5), 289–294 (1997).
   PubMed Web of Science ®Google Scholar
• Gerber MA, Shapiro ED, Burke GS, Parcells VJ, Bell GL. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N. Engl. J. Med.335(17), 1270–1274 (1996).
   PubMed Web of Science ®Google Scholar
• Nadelman RB, Luger SW, Frank E, Wisniewski M, Collins JJ, Wormser GP. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease. Ann. Intern. Med.117(4), 273–280 (1992).
   PubMed Web of Science ®Google Scholar
• Nowakowski J, Nadelman RB, Sell R et al. Long-term follow-up of patients with culture-confirmed Lyme disease. Am. J. Med.115(2), 91–96 (2003).
   PubMed Web of Science ®Google Scholar
• Smith RP, Schoen RT, Rahn DW et al. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann. Intern. Med.136(6), 421–428 (2002).
   PubMed Web of Science ®Google Scholar
• Wormser GP, Ramanathan R, Nowakowski J et al. Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med.138(9), 697–704 (2003).
   PubMed Web of Science ®Google Scholar
• Kowalski TJ, Tata S, Berth W, Mathiason MA, Agger WA. Antibiotic treatment duration and long-term outcomes of patients with early lyme disease from a lyme disease-hyperendemic area. Clin. Infect. Dis.50(4), 512–520 (2010).
   PubMed Web of Science ®Google Scholar
• Pfister HW, Preac-Mursic V, Wilske B, Einhaupl KM. Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study. Arch. Neurol.46(11), 1190–1194 (1989).
   PubMedGoogle Scholar
• Pfister HW, Preac-Mursic V, Wilske B, Schielke E, Sorgel F, Einhaupl KM. Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis. J. Infect. Dis.163(2), 311–318 (1991).
   PubMed Web of Science ®Google Scholar
• Mullegger RR, Millner MM, Stanek G, Spork KD. Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children – a prospective study. Infection19(4), 279–283 (1991).
   PubMed Web of Science ®Google Scholar
• Borg R, Dotevall L, Hagberg L et al. Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis. Scand. J. Infect. Dis.37(6–7), 449–454 (2005).
   PubMed Web of Science ®Google Scholar
• Dotevall L, Hagberg L. Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin. Infect. Dis.28(3), 569–574 (1999).
   PubMed Web of Science ®Google Scholar
• Karkkonen K, Stiernstedt SH, Karlsson M. Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis. Scand. J. Infect. Dis.33(4), 259–262 (2001).
   PubMedGoogle Scholar
• Kohlhepp W, Oschmann P, Mertens HG. Treatment of Lyme borreliosis. Randomized comparison of doxycycline and penicillin G. J. Neurol.236(8), 464–469 (1989).
   PubMed Web of Science ®Google Scholar
• Thorstrand C, Belfrage E, Bennet R, Malmborg P, Eriksson M. Successful treatment of neuroborreliosis with ten day regimens. Pediatr. Infect. Dis. J.21(12), 1142–1145 (2002).
   PubMed Web of Science ®Google Scholar
• Karlsson M, Hammers-Berggren S, Lindquist L, Stiernstedt G, Svenungsson B. Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology44(7), 1203–1207 (1994).
   PubMed Web of Science ®Google Scholar
• Steere AC, Angelis SM. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum.54(10), 3079–3086 (2006).
   PubMed Web of Science ®Google Scholar
• El Moussaoui R, Opmeer BC, de Borgie CA et al. Long term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe community-acquired pneumonia. Chest130(4), 1165–1172 (2006).
   PubMed Web of Science ®Google Scholar
• Stricker RB, Johnson L. The Lyme disease chronicles, continued. Chronic Lyme disease: in defense of the patient enterprise. FASEB J.24(12), 4632–4633; author reply 4633–4634 (2010).
   PubMed Web of Science ®Google Scholar
• Stricker RB, Johnson L. Lyme wars: let’s tackle the testing. BMJ335(7628), 1008 (2007).
   PubMedGoogle Scholar
• Stricker RB, Burrascano J, Winger E. Longterm decrease in the CD57 lymphocyte subset in a patient with chronic Lyme disease. Ann. Agric. Environ. Med.9(1), 111–113 (2002).
   PubMed Web of Science ®Google Scholar
• Stricker RB, Winger EE. Decreased CD57 lymphocyte subset in patients with chronic Lyme disease. Immunol. Lett.76(1), 43–48 (2001).
   PubMed Web of Science ®Google Scholar
• Phillips SE, Mattman LH, Hulinska D, Moayad H. A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated. Infection26(6), 364–367 (1998).
   PubMed Web of Science ®Google Scholar
• Bayer ME, Zhang L, Bayer MH. Borrelia burgdorferi DNA in the urine of treated patients with chronic Lyme disease symptoms. A PCR study of 97 cases. Infection24(5), 347–353 (1996).
   PubMed Web of Science ®Google Scholar
• Marques A, Brown MR, Fleisher TA. Natural killer cell counts are not different between patients with post-Lyme disease syndrome and controls. Clin. Vaccine Immunol.16(8), 1249–1250 (2009).
   PubMed Web of Science ®Google Scholar
• Rauter C, Mueller M, Diterich I et al. Critical evaluation of urine-based PCR assay for diagnosis of Lyme borreliosis. Clin. Diagn. Lab. Immunol.12(8), 910–917 (2005).
   PubMedGoogle Scholar
• Marques AR, Stock F, Gill V. Evaluation of a new culture medium for Borrelia burgdorferi. J. Clin. Microbiol.38(11), 4239–4241 (2000).
   PubMed Web of Science ®Google Scholar
• Tilton RC, Barden D, Sand M. Culture Borrelia burgdorferi. J. Clin. Microbiol.39(7), 2747 (2001).
   PubMedGoogle Scholar
• Strle F, Maraspin V, Lotric-Furlan S, Ruzic-Sabljic E, Cimperman J. Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans. Infection24(1), 64–68 (1996).
   PubMed Web of Science ®Google Scholar
• Strle F, Preac-Mursic V, Cimperman J, Ruzic E, Maraspin V, Jereb M. Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings. Infection21(2), 83–88 (1993).
   PubMed Web of Science ®Google Scholar
• Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N. Engl. J. Med.330(4), 229–234 (1994).
   PubMed Web of Science ®Google Scholar
• Oksi J, Marjamaki M, Nikoskelainen J, Viljanen MK. Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis. Ann. Med.31(3), 225–232 (1999).
   PubMed Web of Science ®Google Scholar
• Hodzic E, Feng S, Holden K, Freet KJ, Barthold SW. Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrob. Agents Chemother.52(5), 1728–1736 (2008).
   PubMed Web of Science ®Google Scholar
• Alban PS, Johnson PW, Nelson DR. Serum-starvation-induced changes in protein synthesis and morphology of Borrelia burgdorferi. Microbiology146(Pt 1), 119–127 (2000).
   PubMed Web of Science ®Google Scholar
• Kersten A, Poitschek C, Rauch S, Aberer E. Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi. Antimicrob. Agents Chemother.39(5), 1127–1133 (1995).
   PubMed Web of Science ®Google Scholar
• Miklossy J, Kasas S, Zurn AD, McCall S, Yu S, McGeer PL. Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. J. Neuroinflammation5, 40 (2008).
   PubMed Web of Science ®Google Scholar
• Brorson O, Brorson SH. In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium. Infection26(3), 144–150 (1998).
   PubMed Web of Science ®Google Scholar
• MacDonald AB. Plaques of Alzheimer’s disease originate from cysts of Borrelia burgdorferi, the Lyme disease spirochete. Med. Hypotheses67(3), 592–600 (2006).
   PubMed Web of Science ®Google Scholar
• Kowalski TJ, Tata S, Berth W, Mathiason MA, Agger WA. Antibiotic treatment duration and long-term outcomes of patients with early lyme disease from a lyme disease-hyperendemic area. Clin. Infect. Dis.50(4), 512–520 (2010).
   PubMed Web of Science ®Google Scholar
• Dattwyler RJ, Wormser GP, Rush TJ et al. A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wien. Klin. Wochenschr.117(11–12), 393–397 (2005).
   PubMed Web of Science ®Google Scholar
• Oksi J, Nikoskelainen J, Hiekkanen H et al. Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study. Eur. J. Clin. Microbiol. Infect. Dis.26(8), 571–581 (2007).
   PubMed Web of Science ®Google Scholar
• Steere AC, Hutchinson GJ, Rahn DW et al. Treatment of the early manifestations of Lyme disease. Ann. Intern. Med.99(1), 22–26 (1983).
   PubMed Web of Science ®Google Scholar
• Steere AC, Malawista SE, Newman JH, Spieler PN, Bartenhagen NH. Antibiotic therapy in Lyme disease. Ann. Intern. Med.93(1), 1–8 (1980).
   PubMed Web of Science ®Google Scholar
• Weber K, Preac-Mursic V, Wilske B, Thurmayr R, Neubert U, Scherwitz C. A randomized trial of ceftriaxone versus oral penicillin for the treatment of early European Lyme borreliosis. Infection18(2), 91–96 (1990).
   PubMed Web of Science ®Google Scholar
• Asch ES, Bujak DI, Weiss M, Peterson MG, Weinstein A. Lyme disease: an infectious and postinfectious syndrome. J. Rheumatol.21(3), 454–461 (1994).
   PubMed Web of Science ®Google Scholar
• Arashima Y, Kato K, Komiya T et al. Improvement of chronic nonspecific symptoms by long-term minocycline treatment in Japanese patients with Coxiella burnetii infection considered to have post-Q fever fatigue syndrome. Intern. Med.43(1), 49–54 (2004).
   PubMed Web of Science ®Google Scholar
• Caperton EM, Heim-Duthoy KL, Matzke GR, Peterson PK, Johnson RC. Ceftriaxone therapy of chronic inflammatory arthritis. A double-blind placebo controlled trial. Arch. Intern. Med.150(8), 1677–1682 (1990).
   PubMedGoogle Scholar
• Vermeulen RC, Scholte HR. Azithromycin in chronic fatigue syndrome (CFS), an analysis of clinical data. J. Transl. Med.4, 34 (2006).
   PubMedGoogle Scholar
• Stricker RB, Green CL, Savely VR, Chamallas SN, Johnson L. Safety of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease. Minerva Med.101(1), 1–7 (2010).
   PubMed Web of Science ®Google Scholar
• Nadelman RB, Arlin Z, Wormser GP. Life-threatening complications of empiric ceftriaxone therapy for ‘seronegative Lyme disease’. South Med. J.84(10), 1263–1265 (1991).
   PubMed Web of Science ®Google Scholar
• Holzbauer SM, Kemperman MM, Lynfield R. Death due to community-associated Clostridium difficile in a woman receiving prolonged antibiotic therapy for suspected lyme disease. Clin. Infect. Dis.51(3), 369–370 (2010).
   PubMed Web of Science ®Google Scholar
• Patel R, Grogg KL, Edwards WD, Wright AJ, Schwenk NM. Death from inappropriate therapy for Lyme disease. Clin. Infect. Dis.31(4), 1107–1109 (2000).
   PubMed Web of Science ®Google Scholar
• Weissenbacher S, Ring J, Hofmann H. Gabapentin for the symptomatic treatment of chronic neuropathic pain in patients with late-stage lyme borreliosis: a pilot study. Dermatology211(2), 123–127 (2005).
   PubMed Web of Science ®Google Scholar
• Stanek G, Reiter M. The expanding Lyme Borrelia complex – clinical significance of genomic species? Clin. Microbiol. Infect.17(4), 487–493 (2011).
   PubMed Web of Science ®Google Scholar